The Investigator's Guide to Clinical Research - Softcover

Über die Autorin bzw. den Autor

David Ginseberg, a board-certified family practitioner, is the Vice President of Field Operations at Wyeth-Ayerst, the research division of American Home Products. Prior to working for Wyeth-Ayerst, David was a practicing physician and principal investigator for more than 15 years. All in all, David has conducted more than 300 industry-sponsored clinical trials. David also created and ran site management organizations, independently and for integrated healthcare systems and managed care organizations. For two years, David worked for Covance, a top five contract research organization, where he was responsible for creating initiatives and interacting with investigators, integrated health systems and academic medical centers on a global basis.

David and his wife Myrna live in Gladwyne, Pennsylvania.

Auszug. © Genehmigter Nachdruck. Alle Rechte vorbehalten.

You are likely hearing more and more about clinical research. It seems as if every time you turn to a newspaper, radio or television, there is an advertisement for patients to enter a clinical trial. Each week, you probably are questioned by at least a few patients about the benefit of some experimental drug that they are sure will be the answer to their needs.

Americans are being inundated with information about promising new drugs. It is indeed an age in which we believe in the potential of modern medicine to resolve all our physical and emotional ills, if not immediately, then in the near future.

We are becoming used to hearing about experimental drugs and the protocols required for their development. Indeed, increasing numbers of our colleagues are conducting clinical trials. In 1990, there were only about 5,000 physicians and pharmacists who conducted a clinical trial of a new drug. This year [1999], more like 50,000 medical professionals have assumed a role as principal investigator in an experimental drug trial. Clearly, the number of professionals participating in clinical trials is exploding, along with the number of patients in clinical trials and the overall number of trials.